Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Feasibility of a musculoskeletal ultrasound intervention to improve adherence in juvenile idiopathic arthritis: a proof-of concept trial.

Favier LA, Ting TV, Modi AC.

Pediatr Rheumatol Online J. 2018 Nov 22;16(1):75. doi: 10.1186/s12969-018-0292-3.

2.

Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.

Fumet JD, Richard C, Ledys F, Klopfenstein Q, Joubert P, Routy B, Truntzer C, Gagné A, Hamel MA, Guimaraes CF, Coudert B, Arnould L, Favier L, Lagrange A, Ladoire S, Saintigny P, Ortiz-Cuaran S, Perol M, Foucher P, Hofman P, Ilie M, Chevrier S, Boidot R, Derangere V, Ghiringhelli F.

Br J Cancer. 2018 Oct;119(8):950-960. doi: 10.1038/s41416-018-0220-9. Epub 2018 Oct 15.

PMID:
30318514
3.

Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer Patients.

Richard C, Fumet JD, Chevrier S, Derangère V, Ledys F, Lagrange A, Favier L, Coudert B, Arnould L, Truntzer C, Boidot R, Ghiringhelli F.

Clin Cancer Res. 2019 Feb 1;25(3):957-966. doi: 10.1158/1078-0432.CCR-18-1940. Epub 2018 Aug 28.

PMID:
30154227
4.

Improving a process to obtain hepatitis B serology among patients treated with infliximab at a large urban children's hospital.

Jean MR, Weaver A, Mastin-Diebold T, Kissinger K, Smitherman EA, Favier L, Danziger-Isakov L, Williams E, Brady RC, Huggins J, Denson LA, Saeed SA, Morgan P, Dykes DMH.

BMJ Open Qual. 2017 Oct 18;6(2):e000092. doi: 10.1136/bmjoq-2017-000092. eCollection 2017.

5.

Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary Results.

Favier LA, Taylor J, Loiselle Rich K, Jones KB, Vora SS, Harris JG, Gottlieb BS, Robbins L, Lai JT, Lee T, Kohlheim M, Gill J, Bouslaugh L, Young A, Griffin N, Morgan EM, Modi AC.

J Rheumatol. 2018 May;45(5):690-696. doi: 10.3899/jrheum.171087. Epub 2018 Feb 1.

PMID:
29419467
6.

Bioremediation: An Overview on Current Practices, Advances, and New Perspectives in Environmental Pollution Treatment.

Hlihor RM, Gavrilescu M, Tavares T, Favier L, Olivieri G.

Biomed Res Int. 2017;2017:6327610. doi: 10.1155/2017/6327610. Epub 2017 Nov 1. No abstract available.

7.

Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer.

Kaderbhai CG, Richard C, Fumet JD, Aarnink A, Ortiz-Cuaran S, Pérol M, Foucher P, Coudert B, Favier L, Lagrange A, Limagne E, Boidot R, Ladoire S, Poudenx M, Ilie M, Hofman P, Saintigny P, Ghiringhelli F.

Oncoimmunology. 2017 Jun 16;6(9):e1339856. doi: 10.1080/2162402X.2017.1339856. eCollection 2017.

8.

Antibiotic Use Does Not Appear to Influence Response to Nivolumab.

Kaderbhai C, Richard C, Fumet JD, Aarnink A, Foucher P, Coudert B, Favier L, Lagrange A, Limagne E, Boidot R, Ghiringhelli F.

Anticancer Res. 2017 Jun;37(6):3195-3200.

PMID:
28551664
9.

Actively evolving subglacial conduits and eskers initiate ice shelf channels at an Antarctic grounding line.

Drews R, Pattyn F, Hewitt IJ, Ng FSL, Berger S, Matsuoka K, Helm V, Bergeot N, Favier L, Neckel N.

Nat Commun. 2017 May 9;8:15228. doi: 10.1038/ncomms15228.

10.

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.

Heudel PE, Fabbro M, Roemer-Becuwe C, Kaminsky MC, Arnaud A, Joly F, Roche-Forestier S, Meunier J, Foa C, You B, Priou F, Tazi Y, Floquet A, Selle F, Berton-Rigaud D, Lesoin A, Kalbacher E, Lortholary A, Favier L, Treilleux I, Ray-Coquard I.

Br J Cancer. 2017 Jan;116(3):303-309. doi: 10.1038/bjc.2016.430. Epub 2017 Jan 10.

11.

Mevalonate kinase deficiency: current perspectives.

Favier LA, Schulert GS.

Appl Clin Genet. 2016 Jul 20;9:101-10. doi: 10.2147/TACG.S93933. eCollection 2016. Review.

12.

Macrolide antibiotics removal using a circulating TiO2-coated paper photoreactor: parametric study and hydrodynamic flow characterization.

Ounnar A, Bouzaza A, Favier L, Bentahar F.

Water Sci Technol. 2016;73(11):2627-37. doi: 10.2166/wst.2016.096.

13.

Use of dedicated gene panel sequencing using next generation sequencing to improve the personalized care of lung cancer.

Kaderbhai CG, Boidot R, Beltjens F, Chevrier S, Arnould L, Favier L, Lagrange A, Coudert B, Ghiringhelli F.

Oncotarget. 2016 Apr 26;7(17):24860-70. doi: 10.18632/oncotarget.8391.

14.

Response surface optimization of experimental conditions for carbamazepine biodegradation by Streptomyces MIUG 4.89.

Popa Ungureanu C, Favier L, Bahrim G, Amrane A.

N Biotechnol. 2015 May 25;32(3):347-57. doi: 10.1016/j.nbt.2014.12.005. Epub 2014 Dec 31.

PMID:
25556120
15.

Photocatalytic degradation of bezacryl yellow in batch reactors--feasibility of the combination of photocatalysis and a biological treatment.

Khenniche L, Favier L, Bouzaza A, Fourcade F, Aissani F, Amrane A.

Environ Technol. 2015 Jan-Feb;36(1-4):1-10. doi: 10.1080/09593330.2014.934740. Epub 2014 Jul 10.

PMID:
25409577
16.

Potential of newly isolated wild Streptomyces strains as agents for the biodegradation of a recalcitrant pharmaceutical, carbamazepine.

Popa C, Favier L, Dinica R, Semrany S, Djelal H, Amrane A, Bahrim G.

Environ Technol. 2014 Nov-Dec;35(21-24):3082-91. doi: 10.1080/09593330.2014.931468. Epub 2014 Jul 3.

PMID:
25244136
17.

A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma.

Selle F, Sevin E, Ray-Coquard I, Mari V, Berton-Rigaud D, Favier L, Fabbro M, Lesoin A, Lortholary A, Pujade-Lauraine E.

Ann Oncol. 2014 Nov;25(11):2191-6. doi: 10.1093/annonc/mdu392. Epub 2014 Sep 10.

PMID:
25210017
18.

Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study.

Vergote IB, Jimeno A, Joly F, Katsaros D, Coens C, Despierre E, Marth C, Hall M, Steer CB, Colombo N, Lesoin A, Casado A, Reinthaller A, Green J, Buck M, Ray-Coquard I, Ferrero A, Favier L, Reed NS, Curé H, Pujade-Lauraine E.

J Clin Oncol. 2014 Feb 1;32(4):320-6. doi: 10.1200/JCO.2013.50.5669. Epub 2013 Dec 23.

PMID:
24366937
19.

[Chronic diarrhea in 43-year-old man].

Larcher R, Andrieu JM, Ramdani M, Passebois L, Favier L, Oziol E, Duffau P.

Rev Med Interne. 2013 Dec;34(12):780-2. doi: 10.1016/j.revmed.2013.06.010. Epub 2013 Sep 5. French. No abstract available.

PMID:
24011846
20.

Detection of synergistic combinations of Baccharis extracts with terbinafine against Trichophyton rubrum with high throughput screening synergy assay (HTSS) followed by 3D graphs. Behavior of some of their components.

Rodriguez MV, Sortino MA, Ivancovich JJ, Pellegrino JM, Favier LS, Raimondi MP, Gattuso MA, Zacchino SA.

Phytomedicine. 2013 Oct 15;20(13):1230-9. doi: 10.1016/j.phymed.2013.06.015. Epub 2013 Jul 30.

PMID:
23906773
21.

Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO.

Ray-Coquard I, Favier L, Weber B, Roemer-Becuwe C, Bougnoux P, Fabbro M, Floquet A, Joly F, Plantade A, Paraiso D, Pujade-Lauraine E.

Br J Cancer. 2013 May 14;108(9):1771-7. doi: 10.1038/bjc.2013.183. Epub 2013 Apr 23.

22.

Pathological response and survival after neoadjuvant therapy for breast cancer: a 30-year study.

Guiu S, Arnould L, Bonnetain F, Dalban C, Favier L, Desmoulins I, Créhange G, Coutant C, Fumoleau P, Coudert B.

Breast. 2013 Jun;22(3):301-8. doi: 10.1016/j.breast.2012.07.012. Epub 2012 Aug 3.

PMID:
22863283
23.

Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours.

Freyer G, Isambert N, You B, Zanetta S, Falandry C, Favier L, Trillet-Lenoir V, Assadourian S, Soussan-Lazard K, Ziti-Ljajic S, Fumoleau P.

Br J Cancer. 2012 Aug 7;107(4):598-603. doi: 10.1038/bjc.2012.304. Epub 2012 Jul 12.

24.

Clinical Images: Digital acrometastasis revealing endometrial cancer relapse.

Ornetti P, Favier L, Varbedian O, Ansemant T.

Arthritis Rheum. 2012 Oct;64(10):3167. doi: 10.1002/art.34603. No abstract available.

25.

Fluid management and risk factors for renal dysfunction in patients with severe sepsis and/or septic shock.

Muller L, Jaber S, Molinari N, Favier L, Larché J, Motte G, Lazarovici S, Jacques L, Alonso S, Leone M, Constantin JM, Allaouchiche B, Suehs C, Lefrant JY; AzuRéa Group.

Crit Care. 2012 Feb 29;16(1):R34. doi: 10.1186/cc11213.

26.

Activation of human leukemic mast cell line LAD2 is modulated by dehydroleucodine and xanthatin.

Vera ME, Persia FA, Mariani ML, Rudolph MI, Fogal TH, Ceñal JP, Favier LS, Tonn CE, Penissi AB.

Leuk Lymphoma. 2012 Sep;53(9):1795-803. doi: 10.3109/10428194.2012.662644. Epub 2012 May 29.

PMID:
22300345
27.

Phase I dose-escalation study of intravenous aflibercept in combination with docetaxel in patients with advanced solid tumors.

Isambert N, Freyer G, Zanetta S, You B, Fumoleau P, Falandry C, Favier L, Assadourian S, Soussan-Lazard K, Ziti-Ljajic S, Trillet-Lenoir V.

Clin Cancer Res. 2012 Mar 15;18(6):1743-50. doi: 10.1158/1078-0432.CCR-11-1918. Epub 2012 Jan 18.

28.

Feasibility and safety of weekly sequential epirubicin-paclitaxel as adjuvant treatment for operable breast cancer patients older than 70 years.

Ladoire S, Rambach L, Quipourt V, Favier L, Ghiringhelli F, Arnould L, Pfitzenmeyer P, Fumoleau P, Coudert B.

Clin Breast Cancer. 2011 Aug;11(4):235-40. doi: 10.1016/j.clbc.2011.06.002. Epub 2011 Jul 7.

PMID:
21737355
29.

Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer.

Guiu S, Gauthier M, Coudert B, Bonnetain F, Favier L, Ladoire S, Tixier H, Guiu B, Penault-Llorca F, Ettore F, Fumoleau P, Arnould L.

Br J Cancer. 2010 Oct 26;103(9):1335-42. doi: 10.1038/sj.bjc.6605939.

30.

Long-term follow-up of HER2-overexpressing stage II or III breast cancer treated by anthracycline-free neoadjuvant chemotherapy.

Guiu S, Liegard M, Favier L, van Praagh I, Largillier R, Weber B, Coeffic D, Moreau L, Priou F, Campone M, Gligorov J, Vanlemmens L, Trillet-Lenoir V, Arnould L, Coudert B.

Ann Oncol. 2011 Feb;22(2):321-8. doi: 10.1093/annonc/mdq397. Epub 2010 Aug 6.

PMID:
20693300
31.

Reduction of the severe sepsis or septic shock associated mortality by reinforcement of the recommendations bundle: a multicenter study.

Lefrant JY, Muller L, Raillard A, Jung B, Beaudroit L, Favier L, Masson B, Dingemans G, Thévenot F, Selcer D, Jonquet O, Capdevila X, Fabbro-Peray P, Jaber S; Sepsi d'Oc study Group in the AzuRéa Group.

Ann Fr Anesth Reanim. 2010 Sep;29(9):621-8. doi: 10.1016/j.annfar.2010.04.007. Epub 2010 Jul 14.

PMID:
20634026
32.

[Management of metastatic HER2-positive breast cancer: present and future].

Guiu S, Coudert B, Favier L, Arnould L, Fumoleau P.

Bull Cancer. 2010 Mar;97(3):365-83. doi: 10.1684/bdc.2010.1040. Review. French.

33.

Spontaneous pyopneumothorax in patients treated with mTOR inhibitors for subpleural pulmonary metastases.

Ladoire S, Beynat C, Diaz P, Coudert B, Favier L, Ghiringhelli F.

Med Oncol. 2010 Sep;27(3):938-41. doi: 10.1007/s12032-009-9311-z. Epub 2009 Sep 19.

PMID:
19768583
34.

Novel anti-ulcer alpha,beta-unsaturated lactones inhibit compound 48/80-induced mast cell degranulation.

Penissi AB, Vera ME, Mariani ML, Rudolph MI, Ceñal JP, de Rosas JC, Fogal TH, Tonn CE, Favier LS, Giordano OS, Piezzi RS.

Eur J Pharmacol. 2009 Jun 10;612(1-3):122-30. doi: 10.1016/j.ejphar.2009.03.052. Epub 2009 Apr 1.

PMID:
19344708
35.

Carcinomatous Meningitis from Unknown Primary Carcinoma.

Favier L, Ladoire L, Guiu B, Arnould L, Guiu S, Boichot C, Isambert N, Besancenot JF, Muller M, Ghiringhelli F.

Case Rep Oncol. 2009 Oct 10;2(3):177-183.

36.

Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy.

Puig PE, Guilly MN, Bouchot A, Droin N, Cathelin D, Bouyer F, Favier L, Ghiringhelli F, Kroemer G, Solary E, Martin F, Chauffert B.

Cell Biol Int. 2008 Sep;32(9):1031-43. doi: 10.1016/j.cellbi.2008.04.021. Epub 2008 May 2.

PMID:
18550395
37.

[Angiogenesis targeting in breast cancer].

Fumoleau P, Coudert B, Mayer F, Isambert N, Favier L, Ferrant E.

Bull Cancer. 2007;94(7 Suppl):F199-206. Review. French.

PMID:
17964997
38.

[Targeting ErbB receptors in breast cancer].

Fumoleau P, Campone M, Coudert B, Mayer F, Favier L, Ferrant E.

Bull Cancer. 2007;94(7 Suppl):F147-70. Review. French.

PMID:
17964992
39.

Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancer.

Favier L, Isambert N, Zanetta S, Ferrant E, Mayer F, Chauffert B, Fumoleau P, Garnier J, Biville F, Coudert B.

Breast. 2008 Feb;17(1):36-41. Epub 2007 Aug 14.

PMID:
17698359
40.
41.

Anti-ulcerogenic activity of xanthanolide sesquiterpenes from Xanthium cavanillesii in rats.

Favier LS, María AO, Wendel GH, Borkowski EJ, Giordano OS, Pelzer L, Tonn CE.

J Ethnopharmacol. 2005 Sep 14;100(3):260-7.

PMID:
15899562
42.

Acute respiratory failure secondary to dilatation of herniated stomach.

Fraisse TC, Favier L, Gatecel C, Peyriere H, De Varax R, Vincent D.

Eur J Intern Med. 2003 Oct;14(6):392-394.

PMID:
14769502
43.

Modeling stability of photoheterotrophic continuous cultures in photobioreactors.

Cornet JF, Favier L, Dussap CG.

Biotechnol Prog. 2003 Jul-Aug;19(4):1216-27.

PMID:
12892484
44.

[Compressive hiatus hernia: an original differential diagnosis of compressive pneumothorax].

Fraisse TC, Favier L, Gatecel C, Peyrière H, de Varax R, Vincent D.

Rev Med Interne. 2003 Aug;24(8):547-8. French. No abstract available.

PMID:
12888177
45.

Antiinflammatory activity from aerial parts of Baccharis medullosa, Baccharis rufescens and Laennecia sophiifolia in mice.

Cifuente DA, Simirgiotis MJ, Favier LS, Rotelli AE, Pelzer LE.

Phytother Res. 2001 Sep;15(6):529-31.

PMID:
11536384
46.

Diterpenes from Laennecia sophiifolia.

Simirgiotis MJ, Favier LS, Rossomando PC, Giordano OS, Tonn CE, Padrón JI, Vázquez JT.

Phytochemistry. 2000 Dec;55(7):721-6.

PMID:
11190387
47.

Anti-inflammatory activity of acetophenones from Ophryosporus axilliflorus.

Favier L, Tonn C, Guerreiro E, Rotelli A, Pelzer L.

Planta Med. 1998 Oct;64(7):657-9.

PMID:
9810273
48.

Growth-inhibitory activities of benzofuran and chromene derivatives toward Tenebrio molitor.

Carrizo R, Sosa ME, Favier LS, Penna F, Guerreiro E, Giordano OS, Tonn CE.

J Nat Prod. 1998 Oct;61(10):1209-11.

PMID:
9784153

Supplemental Content

Loading ...
Support Center